Barclays raised the firm’s price target on Corebridge (CRBG) to $36 from $34 and keeps an Equal Weight rating on the shares. The company’s operating earnings comes in ahead of estimates on strong performance from Life Insurance and solid results in all other segments, the analyst tells investors in a research note.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio